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Identifying presynaptic mechanisms of general anesthetics is critical
to understanding their effects on synaptic transmission. We
show that the volatile anesthetic isoflurane inhibits synaptic
vesicle (SV) exocytosis at nerve terminals in dissociated rat hippo-
campal neurons through inhibition of presynaptic Ca2+ influx
without significantly altering the Ca2+ sensitivity of SV exocytosis.
A clinically relevant concentration of isoflurane (0.7 mM) inhibited
changes in [Ca2+]i driven by single action potentials (APs) by 25 ±
3%, which in turn led to 62 ± 3% inhibition of single AP-triggered
exocytosis at 4 mM extracellular Ca2+ ([Ca2+]e). Lowering external
Ca2+ to match the isoflurane-induced reduction in Ca2+ entry led
to an equivalent reduction in exocytosis. These data thus indicate
that anesthetic inhibition of neurotransmitter release from small
SVs occurs primarily through reduced axon terminal Ca2+ entry
without significant direct effects on Ca2+-exocytosis coupling or
on the SV fusion machinery. Isoflurane inhibition of exocytosis
and Ca2+ influx was greater in glutamatergic compared with
GABAergic nerve terminals, consistent with selective inhibition of
excitatory synaptic transmission. Such alteration in the balance of
excitatory to inhibitory transmission could mediate reduced neu-
ronal interactions and network-selective effects observed in the
anesthetized central nervous system.
GCaMP3 | pHlourin | mechanisms of anesthesia | live cell imaging |
presynaptic
The molecular and cellular mechanisms of anesthetic-inducedamnesia, unconsciousness and immobilization are incom-
pletely understood, particularly for the modern halogenated
ether derivatives like isoflurane. General anesthetics, which are
essential to both medical practice and experimental neuroscience,
have potent and selective effects on neurotransmission (1), in-
cluding both presynaptic actions (reduced neurotransmitter re-
lease) and postsynaptic actions (modulation of receptor function).
These effects contribute to anesthetic-induced reductions in neu-
ronal interactions, which are critical to information processing and
consciousness (2–4). Knowledge of the fundamental synaptic ef-
fects of anesthetics is therefore essential to a molecular and
physiological understanding of anesthetic mechanisms, and to
development of more selective and safer anesthetics.
Although postsynaptic electrophysiological effects of anes-
thetics can be assessed directly using whole cell recordings and
heterologous expression of putative molecular targets, their pre-
synaptic actions have been difficult to resolve by conventional
approaches that do not clearly discriminate between presynaptic
and postsynaptic contributions. Direct evidence for presynaptic
effects of volatile anesthetics includes selective inhibition of glu-
tamate release from isolated nerve terminals (5, 6) and of synaptic
vesicle (SV) exocytosis in intact hippocampal neurons (7). How-
ever, it remains controversial whether these effects involve direct
inhibition of SV exocytosis itself or of upstream targets (8, 9).
Moreover, the mechanism for the greater sensitivity of glutamate
release relative to that of other transmitters is unclear.
Neurotransmitter release is supralinearly dependent on pre-
synaptic Ca2+ influx due to the highly cooperative binding of Ca2+
to synaptotagmin 1, the principal neuronal Ca2+ sensor for
triggering vesicular fusion through increases in the probability of
exocytosis (Pv) (10, 11). We used sensitive quantitative fluores-
cence imaging approaches to characterize the effects of the
widely used volatile anesthetic isoflurane on the Ca2+ sensitivity
of SV exocytosis in cultured rat hippocampal neurons. Although
glutamate and GABA have distinct postsynaptic actions, differ-
ences in the mechanisms and regulation of SV exocytosis from
glutamatergic and GABAergic neurons are not well character-
ized. Because previous studies indicate that glutamate release is
more sensitive to inhibition by volatile anesthetics than GABA
release (12), we compared the effects of isoflurane on the coupling
of Ca2+ influx to exocytosis in glutamatergic and GABAergic
boutons. Our results indicate that the inhibition of SV exocytosis
by isoflurane is driven by a reduction in Ca2+ influx. This reduction
occurs without affecting the apparent sensitivity of exocytosis to
Ca2+. Sensitivity of SV exocytosis to isoflurane is therefore de-
termined by presynaptic targets upstream of exocytosis that de-
termine the magnitude of action potential-evoked Ca2+ influx.
Identification of neurotransmitter-selective effects of anesthetics
on SV exocytosis is critical for understanding their pathway
specific effects on neuronal interactions (13, 14).
Results
The effects of isoflurane on SV exocytosis were examined using
the chimeric reporters of exocytosis vGlut-pHluorin (vG-pH) or
synapto-pHlourin (syn-pH) expressed in dissociated rat hippo-
campal neurons in the presence of 2 or 4 mM extracellular Ca2+
([Ca2+]e). In resting terminals the pHluorin moiety residing in
the acidic SV lumen is quenched, but fluoresces upon exocytosis
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with luminal alkalization. The reporter is then recycled via local
endocytosis and the fluorescence signal is quenched upon
reacidification by the V-type H+ ATPase in the SV membrane
(15). Action potential stimulation (1,500 APs at 10 Hz) in the
presence of the H+ ATPase inhibitor bafilomycin A1 provides a
measure of the kinetics of exocytosis of the total recycling vesicle
pool (TRP; Fig. 1A) (16).
Isoflurane [0.7 mM; twice the minimum alveolar concentra-
tion (MAC) equivalent to the EC50 for rat; ref. 17] significantly
slowed exocytosis kinetics of the total recycling pool (TRP)
(mean exocytosis time constants: τcontrol = 29 ± 3 s, n = 12;
τisoflurane = 44 ± 3 s, n = 12, 95% CI [4.6, 25]; Fig. 1B). Effective
TRP size is a dynamic variable modulating synaptic performance
(18); however the effects of isoflurane were limited to effects on
exocytosis kinetics with no change in TRP size as a fraction of the
total pool size (control 0.51 ± 0.03; isoflurane 0.57 ± 0.03; 95%
CI [−0.14, 0.03]) determined by perfusion with 50 mM NH4Cl to
alkalize all vesicles (Fig. 1B).
We applied stimulation with AP trains of shorter duration to
more closely mimic physiological conditions. A brief burst of AP
firing (100 AP at 10 Hz) led to a rapid rise in vG-pH fluores-
cence (Fig. 2 A and B) corresponding to exocytosis of 0.25 ±
0.026 of the TRP. The average 100-AP response (ΔF100AP) was
inhibited by 55% to 0.11 ± 0.018 of TRP by 0.7 mM isoflurane
(95% CI [−0.07, −0.21]; Fig. 2B). Single bouton analysis showed
that essentially all boutons were inhibited, but the degree of in-
hibition was variable across the entire population of presynaptic
boutons (Fig. 2D).
To narrow the possible mechanisms involved in inhibition of
SV exocytosis, we examined the effect of isoflurane on exocytosis
driven by single AP stimuli. Isoflurane markedly inhibited SV
exocytosis in response to 1 AP from 0.015 ± 0.003 of TRP to
0.0049 ± 0.0009 of TRP (mean inhibition 62 ± 3%; 95% CI
[−0.003, −0.016]) at 4 mM [Ca2+]e (Fig. 3 A and B). Inhibition
was completely reversible: Removal of isoflurane restored exo-
cytosis to control levels (Fig. 3A). Given the cooperative nature
of Ca2+ activation of neurotransmitter release, we investigated
the effect of isoflurane on the Ca2+ dependence of SV exocytosis
in response to a single AP stimulus at varied external Ca2+
concentrations. Single AP-evoked exocytosis was strongly en-
hanced by elevating [Ca2+]e, saturating at high [Ca
2+]e (Fig. 3B).
Isoflurane significantly inhibited exocytosis at all Ca2+ concen-
trations. The effect of isoflurane on SV exocytosis elicited by a
single AP stimulus (Fig. 3) was comparable to that elicited by
multiple-AP trains (Fig. 2).
Strong inhibition of single AP-triggered exocytosis implies that
isoflurane acts either on Ca2+ entry through voltage-gated Ca2+
channels or on SV fusion in response to increased presynaptic
[Ca2+]i. We examined the impact of isoflurane on single-AP
driven Ca2+ influx (18, 19) using the genetically-encoded Ca2+
indicator syn-GCaMP3 (20). Isoflurane reduced the linearized
syn-GCaMP3 response by 30% from 1.2 ± 0.09 to 0.82 ± 0.06 at
4 mM [Ca2+]e (95% CI [−0.13, −0.66]; Fig. 4 A and B), which
indicates that isoflurane inhibits AP-triggered Ca2+ influx (18,
21). Using single AP-triggered activation with [Ca2+]e from 1.5 to
10 mM, Ca2+ influx saturated at high [Ca2+]e, similar to previous
findings in the hippocampus (21) and calyx of Held (22) (Fig.
4B). Isoflurane significantly inhibited Ca2+ influx over this entire
range of [Ca2+]e, which is consistent with a noncompetitive mech-
anism of action with respect to [Ca2+]e. We next examined in-
hibition Ca2+ influx over a range of isoflurane concentrations (with
[Ca2+]e = 4 mM). Isoflurane inhibited single AP-evoked Ca
2+
influx in a concentration-dependent manner with IC50 = 1.4 ±
1.0 mM (Fig. 4C). Significant inhibition occurred within the
clinically relevant concentration range of 0.175 mM to 0.70 mM
(defined as 0.5–2 × MAC).
These experiments strongly suggest that isoflurane inhibits SV
exocytosis by reducing Ca2+ influx as reported by changes in single
AP-triggered syn-GCaMP3 signals. We tested this hypothesis in
two ways. First, we examined the cooperative relationship of
single AP-triggered Ca2+ influx to SV exocytosis, which is well
described by a generalized Hill equation: exocytosis = [Ca2+]i
n/
(Kn + [Ca2+]i
n) (18, 21) that effectively quantifies the efficiency
of exocytosis at different degrees of Ca2+ influx (Fig. 5A). If
isoflurane inhibits exocytosis purely by inhibiting AP-driven Ca2+
entry, then the same quantitative relationship should hold. The
paired isoflurane data fell on the control curve, which indicates
that the effect of isoflurane on SV exocytosis can be attributed
to reductions in [Ca2+]i without significant contributing effects
Fig. 1. Effects of isoflurane on synaptic vesicle recycling pool size and
exocytosis kinetics. (A) Synaptic vesicle exocytosis kinetics were determined
by fitting vGlut-pHluorin fluorescence traces during prolonged action po-
tential (AP) stimulation in the presence of bafilomycin A1 (10 Hz for 150 s;
1,500 APs) for control or 0.7 ± 0.06 mM isoflurane [twice the minimum al-
veolar concentration (MAC); equivalent to EC50 for immobilization in rat] in
the presence of 2 mM extracellular Ca2+ ([Ca2+]e). (B) (Upper) Effect of iso-
flurane on mean exocytosis time constant. Traces were fit with a single ex-
ponential function to determine the time constant for exocytosis of the
recycling pool. **P < 0.01 by two-tailed unpaired t test. (Lower) Effect of
isoflurane on total recycling pool (TRP) size as a fraction of total pool size
(determined using 50 mM NH4Cl), P = 0.21 by two-tailed unpaired t test. n = 12.
Fig. 2. Isoflurane inhibits synaptic vesicle exocytosis evoked by a brief action
potential train. (A) Ensemble average traces of a vGlut–pHluorin transfected
neuron stimulated at 10 Hz for 10 s (100 APs). Fluorescence intensities were
normalized to the peak of a subsequent bafilomycin A1 response (defining the
total recycling pool, TRP). (B) Mean values of vGlut–pHluorin response ampli-
tudes for control or 0.7 ± 0.06 mM isoflurane-treated neurons stimulated with
100 APs in the presence of 2 mM extracellular Ca2+ ([Ca2+]e). Average 100 AP
response (ΔF100AP) was inhibited 55% by isoflurane, ***P < 0.001 by paired
t-test, n = 8. (C) Representative field of vGlut–pHluorin fluorescence images at
rest and difference image for 100 AP stimulation (ΔF100AP) for control or iso-
flurane-treated neurons. (Scale bars: 5 μm.) (D) Histogram of fractional block
of vGlut–pHluorin responses in single boutons stimulated with 100 AP. Mea-
surements from 497 boutons collected in eight experiments.
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on the Ca2+-sensitivity of exocytosis. Second, if inhibition of
Ca2+ influx is sufficient to explain reduced exocytosis, then
simply lowering [Ca2+]e should mimic the effect of isoflurane on
the syn-GCaMP3 signal and replicate isoflurane inhibition of
exocytosis. Reducing [Ca2+]e from 4 mM to 2 mM reduced exo-
cytosis from 0.0146 ± 0.0033 of TRP to 0.0057 ± 0.0012 of TRP
(61 ± 8% inhibition; 95% CI [−0.0010, −0.0166]), which was
comparable to inhibition by 0.7 mM isoflurane to 0.0049 ± 0.0009
of TRP at 4 mM [Ca2+]e (62 ± 3% inhibition; 95% CI [−0.0034,
−0.0158]; 95% CI for difference between 2 mM [Ca2+]e and
4 mM [Ca2+]e + isoflurane [−0.0023, 0.0039]; Fig. 5B, and see
above Fig. 3). Similarly, lowering [Ca2+]e from 4 mM to 2 mM
reduced the syn-GCaMP3 signal from 1.1 ± 0.06 to 0.92 ± 0.02
linearized GCaMP3 units (by 16 ± 2%; 95% CI [−0.030, −0.314]),
comparable to the reduction produced by 0.7 mM isoflurane to
0.82 ± 0.06 at [Ca2+]e = 4 mM (by 25 ± 3%; 95% CI [−0.181,
−0.363]; 95% CI for difference between 2 mM [Ca2+]e and 4 mM
[Ca2+]e + isoflurane [−0.054, 0.254]; Fig. 5C).
To compare the effects of isoflurane on SV exocytosis from
glutamatergic or GABAergic neurons separately, we used live-
cell imaging of GABAergic boutons identified by vGAT–Oyster
550 immunolabeling (23) (Fig. 6A). Single AP-evoked SV exo-
cytosis was measured by syn-pH and Ca2+ influx by syn-GCaMP3
(Fig. 6B) averaged over multiple trials (10–15) across populations
of glutamatergic or GABAergic synapses. Individual gluta-
matergic boutons (vGAT-negative) exhibited greater inhibition by
isoflurane than did GABAergic boutons (vGAT-positive) of peak
syn-pH (62% compared with 38% inhibition; 95% CI [−13, −34])
and syn-GCaMP3 fluorescence (26% compared with 9% inhibi-
tion; 95% CI [−10, −24]) (Fig. 6B). For both neurotransmitter
phenotypes, the effect of isoflurane on Ca2+ influx correlated
with its effect on exocytosis over a range of [Ca2+]e, indicative of
a minimal direct effect on the Ca2+ sensitivity of exocytosis (Fig.
6C). The Ca2+ sensitivity of SV exocytosis for glutamatergic or
GABAergic boutons was not significantly different. Isoflurane
shifted the frequency-response histogram for fractional inhibition
of Ca2+ influx further to the right in glutamatergic boutons com-
pared with GABAergic boutons (Fig. 6D).
Discussion
Using sensitive and specific assays of presynaptic anesthetic ef-
fects, we find that the widely used ether anesthetic isoflurane
inhibits AP-evoked SV exocytosis without affecting the coupling
between Ca2+ influx and exocytosis in mature cultured rat hip-
pocampal neurons. Analysis of individual nerve terminals and
neurons allowed us to isolate presynaptic mechanisms of iso-
flurane on exocytosis without interference from intrinsic neuro-
nal networks or postsynaptic effects. A single AP stimulus provides
a very brief local increase in intracellular free Ca2+, allowing
for high time resolution observations of presynaptic responses.
Isoflurane inhibition of SV exocytosis measured using pHluorin
indicators correlated with reduced Ca2+ influx measured using
syn-GCaMP3; there were no direct effects on the Ca2+ sensitivity
of SV exocytosis. By varying [Ca2+]e, we observed that the Ca
2+
dependence of SV exocytosis follows the same supralinear
relationship in the presence or absence of isoflurane. Moreover,
isoflurane inhibited SV exocytosis from glutamatergic boutons
more potently than from GABAergic boutons in proportion
to the reduction in presynaptic Ca2+ influx. This presynaptic se-
lectivity was not due to an intrinsic difference in the Ca2+ sensi-
tivity of exocytosis between glutamatergic and GABAergic
terminals, which were in fact similar in control conditions. These
findings elucidate fundamental synaptic mechanisms that lead to
neurotransmitter-selective effects that are critical to under-
standing the actions of anesthetics on sensitive neuronal net-
works (13, 14).
Neurotransmitter release is determined by the highly cooper-
ative relationship between Ca2+ entry and SV exocytosis, and by
the number of docked and primed vesicles (readily releasable
pool) (24). Ca2+ entry is regulated mainly by presynaptic ion
channels (e.g., Na+, Ca2+, and K+ channels), presynaptic re-
ceptors, and modulatory cell signaling mechanisms (25). We
have shown previously that isoflurane has transmitter-specific
Fig. 4. Isoflurane reduces action potential-stimulated increases in pre-
synaptic Ca2+ influx. (A) Control (black) and 0.70 ± 0.06 mM isoflurane (red)
ensemble average traces of single AP-evoked [Ca2+] influx determined by
linearized responses synaptophysin–GCaMP3 at 4 mM extracellular Ca2+
([Ca2+]e). Arrow indicates single AP stimulus. (Scale bar: 30% ΔF/F0, 100 ms.)
(B) Inhibition by 0.70 ± 0.06 mM isoflurane of average peak ΔF/F0 evoked by
single AP stimulus as a function of [Ca2+]e. Data are fitted to a single site
binding model using a Levenberg–Marquardt algorithm optimization
method (control: EC50 = 1.3 ± 0.1 mM, Emax = 1.6 ± 0.5, R
2 = 99.8; isoflurane:
EC50= 0.8 ± 0.4 mM, Emax = 0.9 ± 0.2, R
2 = 92.3); both P < 0.05 by two-sample
sum-of-squares F test comparison against the null hypothesis that Emax and
EC50 values are identical. (C) Inhibition of Ca
2+ influx as a function of log
[isoflurane] using synaptopysin-GCaMP3 at 4 mM [Ca2+]e (n = 27). Shaded
area indicates the clinical concentration range of isoflurane for general
anesthesia in rat (0.18–0.7 mM; 0.5–2 × MAC). Data are fitted to a gener-
alized Hill model by least-squares analysis (Imax = 0.92 ± 0.17; IC50 = 1.4 ±
1.0 mM). Inhibition data were all significantly different from paired control
values (*P < 0.05 in two-tailed paired t test).
Fig. 3. Reversibility of isoflurane inhibition and Ca2+ dependence of syn-
aptic vesicle exocytosis. (A) (Upper) Representative vGlut–pHlourin fluores-
cence responses elicited by a single AP at 4 mM extracellular Ca2+ ([Ca2+]e)
for control (black), 0.7 mM isoflurane (red), and wash (blue) conditions.
Arrow indicates single AP stimulus (n = 8 trials each, ∼25 boutons analyzed
per neuron). (Lower) Ensemble average traces of vGlut-pHlourin responses
relative to total releasable pool (TRP) size to single AP stimulation at 4 mM
extracellular Ca2+ ([Ca2+]e) (10 trial average, ∼25 boutons per neuron). (Scale
bar: 0.5% TRP, 100 ms.) (B) Isoflurane inhibition of single AP-stimulated
release is not overcome by elevated extracellular Ca2+ ([Ca2+]e). Average
relative peak (ΔF) evoked by a single AP stimulus expressed as a fraction of
the TRP (n = 7–11). *P < 0.05, **P < 0.01 compared with respective control by
paired t test. Mean isoflurane concentration 0.70 ± 0.06 mM.
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effects on neurotransmitter release from a heterogeneous pop-
ulation of isolated axon terminals (26), and inhibits chemically
evoked glutamate release more potently than release of other
neurotransmitters (12, 26). Pharmacological differences between
glutamate and GABA release could result from synapse-specific
differences in expression and/or coupling of specific isoforms
of ion channels or other proteins regulating SV exocytosis (27,
28). Hippocampal glutamate and GABA containing SVs differ
in their release properties during AP trains as well as in their
adaptive response to strong depolarization (29–31). Different
profiles of presynaptic ion channel expression underlie exocytosis
in glutamatergic and GABAergic synapses (32–34). Our findings
that greater isoflurane sensitivity of glutamatergic compared
with GABAergic SV exocytosis is determined by larger effects on
Ca2+ influx are consistent with transmitter phenotype-specific
differences in expression of the presynaptic ion channels that
determine [Ca2+]i, including distinct subtypes of Nav, Cav, and Kv
channels (35).
Greater sensitivity of glutamate release to anesthetic inhi-
bition is consistent with a net reduction in network excitability
involving both presynaptic and postsynaptic inhibition of gluta-
matergic transmission. The relative anesthetic insensitivity of
GABA release coupled with the potent anesthetic potentiation
of postsynaptic GABAA receptors (1) and increased asynchro-
nous GABA release (36) together enhance net hippocampal
network inhibition (37). The balance of anesthetic actions on
overall network excitability can vary between brain regions, con-
sistent with synaptic and regional differences in anesthetic target
expression and/or functional roles (38). The presynaptic selec-
tivity of volatile anesthetics like isoflurane in suppressing excit-
atory neurotransmission is expected to scale up to reduced
neuronal interactions and information transfer at the network
level, which is considered a leading mechanism for anesthetic-
induced unconsciousness (2, 39).
The molecular mechanisms of general anesthetics involve ef-
fects on both excitatory and inhibitory synaptic transmission (1).
Potentiation of GABAA receptors represents the major action of
most i.v. anesthetics (40, 41), but this mechanism alone does not
account for the lesser target selectivity of volatile anesthetics
compared with i.v. anesthetics (42, 43). Potential synaptic vola-
tile anesthetic targets involved in regulating transmitter release
include glutamate receptors, Nav channels (44), K2P channels
(45), nicotinic acetylcholine receptors (34), Cav channels (46),
neurotransmitter transporters (47, 48), and SNARE proteins (8,
49). Evidence suggests that the presynaptic effects of volatile
anesthetics on neurotransmitter release are mediated by reduced
nerve terminal excitability from inhibition of Nav channels rather
than direct inhibition of Ca2+ influx by inhibition of Cav chan-
nels (7, 44, 50, 51). A critical distinction is between presynaptic
reductions in Ca2+ influx involving direct inhibition of Cav (e.g.,
52) or indirect effects involving alterations in the presynaptic AP
waveform as a result of effects on other ion channels including
Kv and Nav (35, 50, 51, 53). We have previously shown that
hippocampal neuron SV exocytosis is much less sensitive to
isoflurane when evoked by elevated extracellular KCl to open
Cav rather than by electrical simulation of action potentials (7),
which provides further support for a major target upstream of
Ca2+ entry. Recent enhancements in the use of microbial rho-
dopsin-based indicators of membrane voltage that are sensitive
and fast enough to detect presynaptic APs (54, 55) will facilitate
tests of this hypothesis by allowing quantification of anesthetic
effects on AP properties in individual hippocampal boutons.
Fig. 6. Differential effects of isoflurane on synaptic vesicle exocytosis in
glutamatergic and GABAergic neurons is proportional to reduction Ca2+
influx. (A) Representative live-cell image of syn-pH-positive boutons (green,
Left), GABAergic boutons immunolabeled using vGAT–Oyster 550 (red,
Center), and merge shown as yellow (Right), with surrounding vGAT-positive
boutons (red, Right) from untransfected neurons. (Scale bar: 20 μm.) (B Left)
The effect of 0.70 ± 0.06 mM isoflurane on single AP exocytosis is greater in
glutamatergic (vGAT-negative; 62 ± 3% block, n = 11) than in GABAergic
(vGAT-positive; 38 ± 3% block, n = 5) boutons at 4 mM extracellular [Ca2+]e,
***P < 0.001 by unpaired t test. (Insets) Exemplar single AP stimulus (arrow)
syn-pH fluorescence traces before (black) and after (red) isoflurane in glu-
tamatergic (Left) and GABAergic (Right) boutons. (Scale bars: 0.5% TRP,
100 ms.) (B, Right) Effect of isoflurane on presynaptic Ca2+ influx is greater in
glutamatergic (26 ± 2% block, n = 7) than in GABAergic (9.2 ± 2% block, n =
7) boutons at 4 mM extracellular [Ca2+]e, ***P < 0.001 by unpaired t test.
(Insets) Exemplar single AP stimulus (arrow) syn-GCaMP3 fluorescence traces
before (black) and after (red) isoflurane in glutamatergic and GABAergic
boutons. (Scale bars: 30% ΔF/F0, 200 ms.) (C) Effect of 0.70 ± 0.06 mM iso-
flurane on exocytosis as a function of Ca2+ influx in glutamatergic and
GABAergic boutons. Exocytosis determined using syn-pH in response to
single AP relative to TRP is plotted against relative increases in Ca2+ influx
determined using syn-GCaMP3 over a range of [Ca2+]e from 1.5 to 10 mM
under similar conditions to yield the Ca2+ sensitivity of exocytosis (n = 26 for
exocytosis, n = 24 for Ca2+ influx). The curve indicates the data from Fig. 5A.
(D) Cumulative frequency distribution of 0.70 ± 0.06 mM isoflurane in-
hibition of peak [Ca2+]i for GABAergic and glutamatergic boutons. Data
from 272 boutons collected in 12 experiments.
Fig. 5. Effect of isoflurane on synaptic vesicle exocytosis as a function of
Ca2+ influx. (A) Exocytosis determined using synaptophysin-pHlourin (ΔF/F)
in response to a single AP stimulus relative to total releasable pool (TRP) at
1.5, 2, 2.5, 4, 10 mM [Ca2+]e is plotted against Ca
2+ influx determined using
synaptophysin-GCaMP3 (ΔF) under similar conditions in the absence or
presence of 0.70 ± 0.06 mM isoflurane to reveal the Ca2+ sensitivity of exocytosis
(n = 34 for syn-pH experiments, n = 28–33 for syn-GCaMP3 experiments). Data
are fitted to a generalized Hill model [exocytosis = [Ca2+]i
n/(Kn+[Ca2+]i
n), n =
2.9 ± 0.5, K = 2.8 ± 0.2]. (B) Reduction of [Ca2+]e from 4 mM to 2 mM
mimicked the reduction in exocytosis produced by 0.70 ± 0.06 mM isoflurane
at 4 mM [Ca2+]e. *P < 0.05 by one-way ANOVA with Tukey’s post hoc test.
(C) Reduction of [Ca2+]e from 4 mM to 2 mM mimicked the reduction in syn-
GCaMP3 signal produced by 0.70 ± 0.06 mM isoflurane at 4 mM [Ca2+]e.
**P < 0.01 by one-way ANOVA with Tukey’s post hoc test.
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The observation that isoflurane inhibits SV exocytosis in a way
that is quantitatively consistent with reductions in Ca2+ influx
indicates anesthetic target(s) upstream of Ca2+-exocytosis cou-
pling. Our findings in intact hippocampal neurons using sensitive
and direct assays of SV fusion and Ca2+ influx support isoflurane
effects on AP-evoked increases in [Ca2+]i as the principal pre-
synaptic mechanism of action. In contrast, studies using reduced
cell preparations (permeabilized pheochromocytoma cells) have
suggested direct effects of isoflurane on SNARE-mediated SV
fusion (8, 9). This discrepancy might be in part due to the use of
permeabilized tumor cells to measure release of catecholamines,
which is known to involve different mechanisms compared with
typical small SVs, including distinct Ca2+ sensitivity of SV vesicle
exocytosis (56). Whether these differences represent transmitter-
specific differences in release from large dense core vesicles in
pheochromocytoma cells compared with release from small SVs
in hippocampal neurons (26, 55) or artifacts due to use of de-
tergents and ionophores for membrane permeabilization (8, 9)
will require confirmation in intact catecholamine-releasing neu-
rons using live cell imaging approaches. Our findings appear to
contradict a report that isoflurane inhibits ionomycin-evoked
RH414 destaining of rat hippocampal neuron boutons with no
change in neuronal [Ca2+] (9). However, the measurements of
whole cell peak [Ca2+] reported using fura 2 reflect primarily
changes in somatic rather than nerve terminal [Ca2+], and involve
contributions from distinct Ca2+ sources and combinations of Ca2+
channel subtypes due to differences in subcellular expression (57).
Several factors must be considered in interpreting these re-
sults. Experiments were performed at 30 °C to facilitate re-
cording stability and pharmacological analysis. The kinetics of
SV exocytosis and endocytosis are faster at higher physiological
temperatures, but exhibit similar fundamental properties (58).
Cultured hippocampal neurons provide an accessible model for
analyzing nerve terminal physiology, but they lack the tissue
structure of slice preparations and therefore might not fully reflect
properties of typical hippocampal neuron terminals in situ. Dif-
ferences in isoflurane effects on SV exocytosis from other neuronal
types and in other brain regions must also be considered (26).
Our findings indicate that isoflurane reduces presynaptic Ca2+
influx preferentially in glutamatergic compared with GABAergic
boutons imply that at least one of the key molecular players
controlling AP-driven Ca2+ influx is different in these two neu-
ronal subtypes. Further studies are required to identify these
molecular target(s) for isoflurane inhibition (26), but the studies
presented here significantly narrow the list of possibilities. Vol-
atile anesthetics have multiple cellular actions including depression
of glutamate-mediated excitatory transmission and facilitation of
inhibitory GABAergic transmission, in contrast to the principally
GABAergic i.v. anesthetics propofol and etomidate that selec-
tively potentiate GABAA receptors (1, 13, 59). Although both
propofol and the volatile anesthetic sevoflurane produce similar
frontal coherent alpha and slow electroencephalographic oscil-
lations in vivo, probably due to shared GABAergic mechanisms
mediating amnesia and unconsciousness, sevoflurane has addi-
tional distinct encephalographic effects consistent with non-
GABAergic actions (60). The depressive effects of isoflurane on
hippocampal CA1 neuron excitability in rat brain slices involve
primarily nonGABAergic mechanisms including direct depression
of glutamate-mediated excitation (61), which supports an important
role for effects on glutamatergic transmission. A nonGABAergic
mechanism such as suppression of excitatory transmission through
Nav channel blockade (42, 43, 62) is likely to mediate isoflurane-
induced immobility, a ventral spinal anesthetic endpoint (63).
At higher doses, inhibition of glutamatergic transmission likely
contributes to electroencephalographic silence in vivo (64, 65).
Clarification of such fundamental molecular and cellular mech-
anisms for the synaptic selectivity of volatile anesthetics such
as isoflurane in depressing excitatory neurotransmission pre-
synaptically while enhancing inhibitory neurotransmission
postsynaptically provides a framework for explaining the higher
order neuronal network processes relevant to specific anesthetic
endpoints including amnesia, unconsciousness and immobility
(13, 14).
Materials and Methods
Materials and Solutions. Cells were perfused at 0.27 mL min−1 with Tyrode’s
solution (119 mM NaCl, 2.5 mM KCl, 1.5–10 mM CaCl2, 25 mM Hepes buff-
ered to pH 7.4, 30 mM glucose) containing 10 μM 6-cyano-7-nitroquinoxa-
line-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid
(AP5). Isoflurane dissolved in Tyrode’s solution was perfused focally onto
imaged cells via a 150-μm-diameter pipette; delivered isoflurane concen-
trations were determined by gas chromatography (66).
Neuron Imaging. Experiments were approved by the Weill Cornell Medical
College Institutional Animal Care and Use Committee and conformed to NIH
Guidelines for the Care and Use of Animals. Hippocampal CA3–CA1 regions
were dissected from neonatal Sprague–Dawley rats, and cells were dissoci-
ated, plated, and transfected as described (67). Live-cell imaging was per-
formed at 30.0 ± 0.2 °C using an epifluorescence microscope (ZEISS Axio
Observer Z1). Synaptophysin-pHluorin (syn-pH), was used as an optical sen-
sor of SV exocytosis (68, 69); for experiments requiring higher signal-to-noise
ratio, vGlut-pHluorin (vG-pH) was used (58). Synaptophysin-GCaMP3 (syn-
GCaMP3) was used to measure intracellular Ca2+ ([Ca2+]i) in hippocampal
neuron boutons stimulated by field-potential-generated APs. Fluorescence
images were acquired with an Andor iXon1 camera (model DU-897E-BV)
with a solid-state diode pumped 488-nm laser.
Exocytosis and Calcium Measurements. For exocytosis, ΔF of syn-pH and vG-pH
was determined as the difference between the average of 10 frames before
and after a single AP stimulus. Signals were expressed as a fraction or per-
centage of TRP, determined by applying a maximally depleting stimulus
(1,500 APs at 10 Hz) in the presence of bafilomycin A1 (Fig. 1). Superfusion of
0.7 mM isoflurane for 5 min did not affect baseline fluorescence or maximal
fluorescence elicited by 1,500 APs in the presence of bafilomycin A (TRP; ΔF <
4%) of either syn-pH or vG-pH transfected boutons. For Ca2+ influx, ΔF of
syn-GCaMP3 was determined as the difference between the average of 10
frames before and the 5 highest points after a single AP stimulus. Changes in
fluorescence were normalized to syn-GCaMP intensity at Ca2+ saturation
(FMAX) determined by applying 200 μM ionomycin, which caused a 6.1- to
6.6-fold increase in syn-GCaMP3 fluorescence in agreement with previous
results (19). Changes in GCaMP3 fluorescence (ΔF/F) are related to changes
in intracellular Ca2+ according to a generalized Hill equation (Vmax = 1, k =
9.077, n = 2.5; adjusted R2 = 0.997; ref. 19), and can be linearized to the
single AP signal obtained using the linear indicator Magnesium Green (Life
Technologies) as (ΔF/F)linear = (((ΔF/F)/FMAX) × kn)/(1 − ((ΔF/F)/FMAX))(1/n).
Superfusion of 0.7 mM isoflurane for 5 min did not affect baseline fluores-
cence (ΔF < 4%) of syn-GCaMP3 transfected boutons.
Image and Data Analysis. Images were analyzed in ImageJ (rsb.info.nih.gov/ij)
using a custom plugin (rsb.info.nih.gov/ij/plugins/time-series.html). Rabbit
vGAT-Oyster 550 luminal domain antibody was used to identify GABAergic
neurons (23). Values are shown as mean ± SEM. ANOVA with Tukey’s post hoc
test, Student’s orWelch’s unpaired t test (P < 0.05), and 95% confidence intervals
on the difference of the means were used to determine statistical significance.
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